[Back to Our Trials]

STELLAR-001: A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors

Condition: Breast Cancer, Colorectal Cancer, Prostate Cancer, Renal Cancer, Urothelial Cancer


Go To Trial Homepage


For more information you may call clinical trials department directly at 732-390-7750 or email us at astera.clinicaltrial@asterahealthcare.org.